Response: Use of Drug Sample Medications

References

1. ↵
   Moy E, Bartman BA, Weir MR. Access to hypertensive care. Effects of income, insurance, and source of care. Arch Intern Med 1995; 155; 1497–502.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Becker G. Effects of being uninsured on ethnic minorities’ management of chronic illness. West J Med 2001; 175: 19–23.

   OpenUrlCrossRefPubMedWeb of Science
3. Baker DW, Sudano JJ, Albert JM, Borawski EA, Dor A. Lack of health insurance and decline on overall health in late middle age. N Engl J Med 2001; 345: 1106–12.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Kalb JL, Marazon DJ, Snow RJ. Potential barriers to control of blood pressure. J Am Osteopath Assoc 2002; 102: 209–13.

   OpenUrlPubMed
5. ↵
   Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–63.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med 2002; 34: 729–31.

   OpenUrlPubMedWeb of Science
7. ↵
   Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med 1996; 5: 201–6.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract 2000; 49: 811–6.

   OpenUrlPubMedWeb of Science